Research and Development
According to Gartner research, in the past year, 83% of research and development (R&D) leaders report that the level of scrutiny on portfolio decisions from senior leaders and the board has increased. Unfortunately, R&D portfolios are not healthy when measured by standard assessment criteria such as balance across risk, value, and time horizon. The path forward is to increase the quality of the decision-making associated with the portfolio. R&D leaders who have increased the quality of which projects and initiatives are included in the portfolio, and which ones are not, found improved portfolio health by as much as 72% on certain key factors. So, what best practices do R&D leaders need to improve portfolio health? In this complimentary webinar, you’ll hear about the five markers of high-quality portfolio decisions and best practices for putting these markers into action.
Get to know why most R&D leaders believe their current portfolio health is poor
Learn about the impact of the 5 markers of high-quality portfolio decisions on portfolio health
Explore best practices to enact the 5 markers and drive significant impact on improving portfolio health
Return to this web page to watch the webinar. Contact us at email@example.com with questions about viewing this webinar.